A glucan from Ganoderma lucidum: Structural characterization and the anti-inflammatory effect on Parkinson's disease via regulating dysfunctions of intestinal microecology and inhibiting TLR4/MyD88/NF-κB signaling pathway

Li Chen, Yingjie Ling, Jiaxin Sun, Shuo Zhou, Yao Xiao, Xinyu Zou, Xiudong Yang and Yan Zhang

Journal of Ethnopharmacology, 2025, 343, 119446
DOI: 10.1016/j.jep.2025.119446

Treatment Approaches To Anxiety and Depression in Parkinson’s Disease

Phelan E. Maruca-Sullivan, Kyra Doumlele, Samantha Keller and Kirsten M. Wilkins

Curr Geri Rep, 2025, 14
DOI: 10.1007/s13670-025-00436-z

Unveiling the Journey from the Gut to the Brain: Decoding Neurodegeneration–Gut Connection in Parkinson’s Disease

Kritika Bhardwaj, Aditya A. Singh and Hemant Kumar

ACS Chem. Neurosci., 2024, 15, 2454
DOI: 10.1021/acschemneuro.4c00293

The Role of Gut-Brain Axis in Modulating the Impact of Sterile Inflammation on Neuroimmune Responses in Neurodegenerative Diseases: Alzheimer’s Disease and Parkinson’s Disease

Pei-Zhi Ling, Ka-Hing Wong, Yuen-Shan Ho, Wai-Yin Cheng and Raymond Chuen-Chung Chang

Neuroimmunomodulation, 2025, 32, 220
DOI: 10.1159/000547746

Faecalibacterium prausnitzii, depleted in the Parkinson’s disease microbiome, improves motor deficits in α-synuclein overexpressing mice

Anastasiya Moiseyenko, Giacomo Antonello, Aubrey M. Schonhoff, Joseph C. Boktor, Kaelyn Long, Blake Dirks, Anastasiya D. Oguienko, Alexander Viloria Winnett, Patrick Simpson, Dorsa Daeizadeh, Rustem F. Ismagilov, Rosa Krajmalnik-Brown, Nicola Segata, Levi D. Waldron and Sarkis K. Mazmanian

npj Parkinsons Dis., 2026
DOI: 10.1038/s41531-026-01287-x

Fecal Microbiota Transplantation for Treatment of Parkinson Disease

Filip Scheperjans, Reeta Levo, Berta Bosch, Mitja Lääperi, Pedro A. B. Pereira, Olli-Pekka Smolander, Velma T. E. Aho, Nora Vetkas, Lotta Toivio, Veera Kainulainen, Tatyana D. Fedorova, Perttu Lahtinen, Rebekka Ortiz, Valtteri Kaasinen, Reetta Satokari and Perttu Arkkila

JAMA Neurol, 2024, 81, 925
DOI: 10.1001/jamaneurol.2024.2305

Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective

Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi and Shyam Sunder Sharma

Probiotics & Antimicro. Prot., 2025, 17, 2438
DOI: 10.1007/s12602-024-10433-x

Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature

Ana Isabel Beltrán-Velasco, Manuel Reiriz, Sara Uceda and Víctor Echeverry-Alzate

IJMS, 2024, 25, 3010
DOI: 10.3390/ijms25053010

The microbiota–gut–brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets

Millicent N. Ekwudo, Carolina Gubert and Anthony J. Hannan

The FEBS Journal, 2025, 292, 1282
DOI: 10.1111/febs.17102

A Narrative Review on the Advance of Probiotics to Metabiotics

Hye Ji Jang, Na-Kyoung Lee and Hyun-Dong Paik

J. Microbiol. Biotechnol., 2024, 34, 487
DOI: 10.4014/jmb.2311.11023

Effects of Probiotics on Neurodegenerative Disease-Related Symptoms and Systemic Inflammation: A Systematic Review

Fengya Zhu, Shao Yin, Yuan Wang, Yue Zhong, Qiang Ji and Jie Wu

IJGM, 2024, Volume 17, 5941
DOI: 10.2147/IJGM.S499406

Aging and the microbiome: implications for health and disease

WenTing Gao, Hye-Yeon Lee and Kyung-Jin Min

BMB Rep, 2026, 59, 40
DOI: 10.5483/BMBRep.2025-0152

Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson’s Disease and Other Synucleinopathies

Jose-Alberto Palma and Roland D. Thijs

Journal of Parkinson’s Disease, 2024, 14, S81
DOI: 10.3233/JPD-230173

Therapeutic role of probiotics in motor and non-motor symptoms of Parkinson’s disease

Salomón Páez-García, Daniel Hernández-Triana, Felipe Esparza-Salazar, George E. Barreto, Maria Cruz Rodriguez-Oroz and Miguel Germán Borda

Explor Neuroprot Ther, 2025, 5
DOI: 10.37349/ent.2025.1004129

Analysis of parkinson’s disease patients with Gastrointestinal symptoms using structural and functional magnetic resonance imaging

Yuchao Tai, Wei Huang, Yongyun Zhu, Bin Liu, Fang Wang, Zhaochao Liu, Chunyu Liang, Jin Tian, Hongju Yang, Huiren and Xinglong Yang

Brain Imaging and Behavior, 2025, 19, 1286
DOI: 10.1007/s11682-025-01057-y

The Gut‐Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications

Elisa Menozzi, Anthony H.V. Schapira and Per Borghammer

Movement Disord Clin Pract, 2025, 12, 904
DOI: 10.1002/mdc3.70029

Parkinson’s disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons

Satyam Yadav and Rojin G. Raj

Neuroscience, 2025, 581, 1
DOI: 10.1016/j.neuroscience.2025.07.003

Effects of probiotics on neurodegenerative diseases

Juan G. Córdova, Edison H. Freile, Prisca del P. Acosta, Paolo T. Cañarte, José N. Castillo, Ma A. Núñez and Melpisa P. Andrade

Int J Res Med Sci, 2025, 13, 4465
DOI: 10.18203/2320-6012.ijrms20253209

Concepts and criteria defining emerging microbiome applications

Tanja Kostic, Michael Schloter, Paulo Arruda, Gabriele Berg, Trevor C. Charles, Paul D. Cotter, George Seghal Kiran, Lene Lange, Emmanuelle Maguin, Annelein Meisner, Leo van Overbeek, Yolanda Sanz, Inga Sarand, Joseph Selvin, Effie Tsakalidou, Hauke Smidt, Martin Wagner and Angela Sessitsch

Microbial Biotechnology, 2024, 17
DOI: 10.1111/1751-7915.14550

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review

Efthalia Angelopoulou, Evangelia Stanitsa, Claire Chrysanthi Karpodini, Anastasia Bougea, Dionysia Kontaxopoulou, Stella Fragkiadaki, Christos Koros, Vasiliki Epameinondas Georgakopoulou, George Fotakopoulos, Yiannis Koutedakis, Christina Piperi and Sokratis G. Papageorgiou

Medicina, 2023, 59, 1454
DOI: 10.3390/medicina59081454

Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches

Yildiz Degirmenci, Efthalia Angelopoulou, Vasiliki Epameinondas Georgakopoulou and Anastasia Bougea

Medicina, 2023, 59, 1756
DOI: 10.3390/medicina59101756

Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson’s disease treatment

Zimo Zang, Fang Yang, Liang Qu, Minghui Ge, Liang Tong, Lihui Xue, Xiuye Sun and Ying Hai

Front. Aging Neurosci., 2025, 17
DOI: 10.3389/fnagi.2025.1640389

ClpL Chaperone as a Possible Component of the Disaggregase Activity of Limosilactobacillus fermentum U-21

Rahaf N. Al Ebrahim, Maria G. Alekseeva, Sergey V. Bazhenov, Vadim V. Fomin, Dilara A. Mavletova, Andrey A. Nesterov, Elena U. Poluektova, Valeriy N. Danilenko and Ilya V. Manukhov

Biology, 2024, 13, 592
DOI: 10.3390/biology13080592

A water-based probiotic supplement shows antipathogenic activity against Clostridium perfringens, Klebsiella pneumoniae, and Listeria monocytogenes

Grace B. Hatton, Jawal Said, Alexandra Peremezhko, Andre Gessner and Simon Gaisford

International Journal of Pharmaceutics, 2026, 693, 126669
DOI: 10.1016/j.ijpharm.2026.126669

Gut bacteria: an etiological agent in human pathological conditions

Md Minarul Islam, Nasir Uddin Mahbub, Seong-Tshool Hong and Hea-Jong Chung

Front. Cell. Infect. Microbiol., 2024, 14
DOI: 10.3389/fcimb.2024.1291148

Gut Microbiota: An Immersion in Dysbiosis, Associated Pathologies, and Probiotics

Valentina Origüela and Alvaro Lopez-Zaplana

Microorganisms, 2025, 13, 1084
DOI: 10.3390/microorganisms13051084